Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2383]

Breast cancer prevention in high-risk post-menopausal women

Prof Jack Cuzick - Queen Mary University of London, London, UK

Breast cancer prevention in high-risk post-menopausal women ( Prof Jack Cuzick - Queen Mary University of London, London, UK )

Accelerated partial breast irradiation versus whole breast irradiation in...

Dr Icro Meattini - Univerity of Florence, Florence, Italy

Accelerated partial breast irradiation versus whole breast irradiation in patients with early breast cancer ( Dr Icro Meattini - Univerity of Florence, Florence, Italy )

Evaluating the combination of atezolizumab with neoadjuvant chemotherapy for...

Dr Luca Gianni - San Raffaele Hospital, Milan, Italy

Evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of triple-negative breast cancer ( Dr Luca Gianni - San Raffaele Hospital, Milan, Italy )

Preventative effects of anastrozole in post-menopausal women who are at high...

Prof Jack Cuzick - Queen Mary University of London, London, UK

Preventative effects of anastrozole in post-menopausal women who are at high-risk for developing breast cancer ( Prof Jack Cuzick - Queen Mary University of London, London, UK )

How effective is accelerated partial breast irradiation in patients with early...

Dr Icro Meattini - Univerity of Florence, Florence, Italy

How effective is accelerated partial breast irradiation in patients with early breast cancer? ( Dr Icro Meattini - Univerity of Florence, Florence, Italy )

Addition of S-1 to post-operative endocrine therapy for patients with hormone...

Prof Masakazu Toi - Kyoto University, Kyoto, Japan

Addition of S-1 to post-operative endocrine therapy for patients with hormone receptor-positive HER2-negative breast cancer ( Prof Masakazu Toi - Kyoto University, Kyoto, Japan )

QUANTUM-R: Transfusion independence in patients with FLT3-ITD-mutated R/R AML...

Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA

QUANTUM-R: Transfusion independence in patients with FLT3-ITD-mutated R/R AML treated with quizartinib or salvage chemotherapy ( Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA )

Ibrutinib plus venetoclax for the first-line treatment of CLL/SLL: Results from...

Prof Constantine Tam - Peter MacCallum Cancer Centre, Melbourne, Australia

Ibrutinib plus venetoclax for the first-line treatment of CLL/SLL: Results from the CAPTIVATE study ( Prof Constantine Tam - Peter MacCallum Cancer Centre, Melbourne, Australia )

FiTNEss: Investigating frailty-adjusted therapy in transplant non-eligible...

Prof David Cairns - University of Leeds, Leeds, UK

FiTNEss: Investigating frailty-adjusted therapy in transplant non-eligible patients with NDMM ( Prof David Cairns - University of Leeds, Leeds, UK )

Weekly wKRd-D in newly diagnosed multiple myeloma achieves unprecedented results

Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA

Weekly wKRd-D in newly diagnosed multiple myeloma achieves unprecedented results ( Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA )

Benefits of apixaban among venous thromboembolism patients with active cancer

Dr Alexander Cohen - Guys and St Thomas, London, UK

Benefits of apixaban among venous thromboembolism patients with active cancer ( Dr Alexander Cohen - Guys and St Thomas, London, UK )

Inotuzumab ozogamicin and chemotherapy with or without blinatumomab in...

Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA

Inotuzumab ozogamicin and chemotherapy with or without blinatumomab in Philadelphia chromosone-negative ALL ( Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA )

More from ecancer